31Dec 2016

VANADIUM (V) COMPLEXES CONTAINING 1, 2, 4-TRIAZOLE MOIETY AND THEIR ANTIMICROBIAL ACTIVITY.

  • Chemistry Department, Faculty of Science, AlBaha University, Al-Baha, KSA.
  • Chemistry Department, Faculty of Science, Al Azhar University, Assiut Branch, Assiut 71524, Egypt.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Novel oxo-/dioxo-vanadium(V) complexes with the bidentate 4-amino-5-mercapto-3-phenyl-1,2,4-triazole (L1) and the tridentate 4-Amino-3-hydrazino-5-mercapto-1,2,4-triazole (L2) ligands have been synthesized and characterized using elemental analysis, IR, 1H-NMR, electronic spectra and thermal studies. Both ligands (L1 and L2) coordinate to the vanadium ions through sulphur and nitrogen toms. The results indicate thatthe prepared vanadium(V) complexes exhibited distorted square-pyramidal geometry. The antimicrobial activities of the ligands and their complexes show moderate activity.The results showed enhanced activity of metal complexes over their parent ligands.

  1. Zabin S and Abdelbaset M, J. Chem.,7 (3) (2016) 322.
  2. Singh K, Kumar M, and Kumar V, International Journal of Chemical Science and Technology 6(1) (2016) 26.
  3. Klingele M. H, Brooker S, Coord. Chem. Rev., 241, (2003) 119.
  4. Haasnoot J.G., Coord. Chem. Rev., 200– 202, (2000) 131.
  5. Aromi G., Barrios L.A., Roubeau O., Gamez P., Coord. Chem. Rev., 255, (2011) 485.
  6. Nadeem H, Mohsin M, Afzaal H, Riaz S, Advances in Microbiology 3 (2013) 366.
  7. Thakur A., Gupta P. S., kumarshukla P., Verma A, and Pathak P, Int. J. Curr. Res. Aca. Rev., 4(2) (2016) 277.
  8. Patil B. S., Krishnamurthy G., Shashikumar N. D., Lokesh M. R., and BhojyaNaik H. S., J. Chem., (2013), 2-7.
  9. Bayrak H., Demirbas A., Demirbas N., and Karaoglu S. A., J. Med. Chem., 44(11) (2009) 4362.
  10. Padmavathi V., Thriveni P., Sudhakar Reddy G., and Deepti D., J. Med. Chem., 43(5) (2008) 917.
  11. Soni B., Ranawat M. S., Sharma R., Bhandari A., and Sharma S., J. Med. Chem., 45(7) (2010) 2938.
  12. Xu J., Cao Y., Zhang J., J. Med. Chem., 46(7) (2011) 3142.
  13. Tozkpran B., Kupeli E., Yesilada E., and Ertan M., Bioorganic and Medicinal Chemistry 15(4) (2007) 1808.
  14. Holla B. S., Veerandra B., Shivananda M. K., and Poojary B., J. Med. Chem., 38(7-8) (2003) 759.
  15. Duran A., Dogan H. N., and Rollas S., Il Farmaco, 57( 7) (2002) 559.
  16. Abdel-Aal M. T., El-Sayed W. A., El-Kosy S. M., and El-Ashry E. S. H., Archiv der Pharmazie-Chemistry in Life Sciences, 341(5) (2008) 307.
  17. Kucukguzel I., Kucukguzel S. G., Rollas S., and. Kiraz M, Med. Chem. Lett., 11(13) (2001) 1703.
  18. Foroumadi A., Kiani Z., and Soltani F., IlFarmaco, 58(11) (2003) 1073.
  19. Labanauskas L., Udrenaite E., Gaidelis P., and Brukštus A., IlFarmaco, 59(4) (2004)255.
  20. Almasirad A., Tabatabai S. A., Faizi M, Med. Chem. Lett., 14(24) (2004) 6057.
  21. Kucukguzel I., Kucukguzel S. G., Rollas S., IlFarmaco, 59 (11) (2004) 893.
  22. Varvaresou A., Siatra-Papastaikoudi T., Tsotinis A., Tsantili-Kakoulidou A., and Vamvakides A., IlFarmaco, 53, 5 (1998) 320.
  23. Modzelewska-Banachiewicz, Banachiewicz J., Chodkowska A., Jagie??o-Wójtowicz E., and Mazur L., Eur. J. Med. Chem., 39(10) (2004) 873.
  24. Kelvin Cooper and Kenneth Richardson, "Bistriazole antifungal agents.", U.K. patent application No.US 4466974 A, 1984.
  25. Goss P.E., Breast Cancer Res. Treat. 49 (Suppl 1) (1998) S59–65.
  26. Philip N. Edwards, and Michael S. Large, "(Substituted aralkyl) heterocyclic compounds." US patent 4,935,437, 1990.
  27. Lang M., Batzl C., Furet P., Bowman R., Hausler A., Bhatnagar A., Steroid Biochem. Mol. Biol., 44 (4 - 6) (1993) 421.
  28. Clemons M., Coleman R.E., Verma S., Cancer Treat. Rev. 30 (2004)325.
  29. Kalshetty B. M., Gani R. S.,Karabasannavar S.S. &.Kalashetti M.B, Global Journal of Science Frontier Research, Chemistry 13 Issue 2 Version 1.0 (2013).
  30. Toragalmath S. S., Patil S. A., Unki S. N., Halasangi B. M. and Badami P. S., Der PharmaChemica, 7(6) (2015) 147.
  31. Alias M., Seewan A. N., Shakir C., Mohammad F. ,Int. J. Pharm., 4(2) (2014) 126.
  32. Haddad R., Yousif E. and Ahmed A., SpringerPlus 2 (2013) 510.
  33. Siddappa K, Shikkargol R. K. and Angadi S. D., proc Indian Natn. Sci.Acad, 75 (2) (2009) 73.
  34. Abdul Hameed A., Hassan F., International Journal of Applied Science andTechnology 4 (2) (2014) 202.
  35. Mahal A.; Abu?El?Halawa R.; Zabin S. A.; Ibrahim, M.; Al?Refai M.; Kaimari, T. World J. Org. Chem., 3(1) (2015) 1.
  36. Begum A., Sreedhar B, Laxmi K, Mamatha P and Sarala Devi Ch., RJPBCS 5(1) (2014) 408.
  37. Narayana B. and Gajendragad M. R., Tr. J. Chemistry 21 (1997)
  38. Singh, K.; Kumar, Y.; Puri, P.; Singh, G. Bioinorg Chem. Appl. (2012) 9.
  39. Maurya M. R., Khurana S., Zhang W. and Rehder D., J. Chem. Soc., Dalton Trans., (2002) 3015.
  40. Liu H.X., Wang W., Wang X., Tan, M.Y., J. Coord. Chem. 33(4) (1994) 347.
  41. Asgedom G., Sreedhara A., Kivikoski J., Valkonen J., Rao C.P., Chem. Soc., Dalton  Trans. (14) (1995) 2459.
  42. Hazra A., Kumar Barik A., Pal S., Gupta S., Roy S., Butcher R. J., Shie-Ming Peng, Lee G.H., Kar S. K., Polyhedron 26 (2007) 773.
  43. Samanta S., Ghosh D., Mukhopadhyay S., Endo A., Weakley T. R., Chaudhury M., Inorg.Chem. 42 (2003) 1508.
  44. Kwiatkowski E., Romanowski G., Nowicki W., Kwiatkowski M., Suwinska K., Polyhedron 22 (2003) 1009.
  45. Howarth, O.W. and Hunt J.R., J. Chem. Soc., Dalton Trans. (9), (1979) 1388.
  46. Hammam A. M., EL-Gahami M. A., Khafagi Z. A., AL-Salimi M. S. and Ibrahim S. , J. Mater. Environ. Sci. 6 (6) (2015) 1596.
  47. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  48. Silvertistein R. M., Bassler G.C. and Morrill T.C, “Spectormetirc Identification of Organic Compounds”, 4th Ed., John Wiley and Sons, 1981.
  49. Shakir M., Parveen S., Begum N., and Azim Y., Polyhedron, 22(24) (2003) 3181.
  50. Shakir M., Parveen S., Begum N., and Chingsubam P., Transition Met. Chem, 29 (2004) 196.
  51. Xavier R. J., Gobinath E., Spectro ChimicaActa Part A: Molecular and Biomolecular Spectroscopy, 86 (2012) 242.
  52. Guédira F., Castellà-Ventura M., Zaydoun S., Elhajji A., Lautié A., and Idrissi M. S., SpectrochimicaActa Part A: Molecular and Biomolecular Spectroscopy, 73(4) (2009) 738.
  53. Zhao P. S., Ming Xu J., Zhang W. G., Jian F. F., and Zhang L., Struct. Chem, 18 (2007) 993.
  54. Roubeau O., Gubbens P. C. M., Visser D., Blaauw M., Dalmas de Re´otier P., Yaouanc A., Haasnoot J.G., Reedijk J., Sakarya S., Jayasooriya U. A., Cottrell S. P., King P.J.C., Phys. Lett., 395(4–6) (2004) 177.
  55. Mahajan S., Singh B., Sheikh H.N., Kalsotra B.L. Chem. Sci. Trans., 1(1) (2012) 23.
  56. Lic?´nia G. Justino, M. Lu?´sa Ramos, M. MadalenaCaldeira, Victor M.S. Gil. Inorg. Chim. Acta311 (2000) 119.
  57. Refat M. S., El-Korashy S. A. and Hussien M. A., Canadian Chemical Transactions, 2 (1) (2014) 97.
  58. MohanaPriyadarshini K., Chandramohan A., AnandhaBabu G., Ramasamy P., Optik 125 (2014) 1390.
  59. Sanche-Lara, E., Sanchez-Lombardo I., Perez-Benitez A., Mendoza A., Alamo M. F., Vergara E. G., J. Clust. Sci. 26(3) (2015) 901.
   

[Mohamed Abdelbaset and Sami A. Zabin. (2016); VANADIUM (V) COMPLEXES CONTAINING 1, 2, 4-TRIAZOLE MOIETY AND THEIR ANTIMICROBIAL ACTIVITY. Int. J. of Adv. Res. 4 (Dec). 1861-1871] (ISSN 2320-5407). www.journalijar.com

Dr. Mohamed Abdelbaset
Chemistry Department, Faculty of Science, Al Azhar University, Assiut Branch, Assiut 71524, Egypt

DOI:

Article DOI: 10.21474/IJAR01/2594      
DOI URL: http://dx.doi.org/10.21474/IJAR01/2594

Download Full Paper

Download PDF No. of Downloads: 29 | No. of Views: 109